Literature DB >> 19391627

Syntheses and vibrational circular dichroism spectra of the complete series of [Ru((-)- or (+)-tfac)(n)(acac)(3-n)] (n = 0 approximately 3, tfac = 3-trifluoroacetylcamphorato and acac = acetylacetonato).

Hisako Sato1, Yukie Mori, Yutaka Fukuda, Akihiko Yamagishi.   

Abstract

Twenty four kinds of Ru(III) complexes expressed by the formula of Delta- or Lambda-[Ru((-)- or (+)-tfac)(n)(acac)(3-n)] (n = 1, 2, and 3, (-)- or (+)-tfac = (-)- or (+)-3-trifluoroacetylcamphorato and acac = acetylacetonato) were prepared in a pure diastereomeric form. The separation of these diastereomers was accomplished chromatographically by rational use of two antipodal chiral columns. The separated complexes were identified by means of mass spectra, (1)H NMR, electronic circular dichroism, and partly X-ray diffraction analyses. When a pair of Delta- and Lambda-[Ru(acac)(3)] (n = 0) was added to this group, they constituted the complete series of mixed ligand complexes including ligand chirality under the condition of no mixing of chiral ligands. The vibrational circular dichroism (VCD) spectra of their CDCl(3) solutions were recorded in the wavenumber region of 1000 approximately 1800 cm(-1). The results provided a benchmark for systematically examining the effects of the stereochemical properties on VCD spectra such as the degree of ligand substitution, DeltaLambda configurations, geometrical isomerism, and ligand chirality. As a result, the geometrical isomers of trans- or cis-[Ru((-)- or (+)-tfac)(2)(acac)] and mer- or fac-[Ru((-)- or (+)-tfac)(3)] were clearly differentiated by their VCD signals, which was hardly possible from their IR spectra alone.

Entities:  

Year:  2009        PMID: 19391627     DOI: 10.1021/ic801971p

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

Review 1.  VCD studies on chiral characters of metal complex oligomers.

Authors:  Hisako Sato; Akihiko Yamagishi
Journal:  Int J Mol Sci       Date:  2013-01-07       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.